692
Views
3
CrossRef citations to date
0
Altmetric
REVIEW

Association Between Vitamin Deficiencies and Ophthalmological Conditions

, , &
Pages 2045-2062 | Received 25 Apr 2023, Accepted 12 Jul 2023, Published online: 19 Jul 2023

References

  • Serhan HA, H. A, Irshaidat S, Ameer MA, Asghar MS, Tahir MJ. Ophthalmic manifestations of nutritional deficiencies: a mini review. J Fam Med Prim Care. 2022;11(10):5899–5901.
  • El-Sheikh M. Vitamin deficiencies in relation to the eye. Br J Ophthalmol. 1960;44(7):406–414.
  • Wolf G. The discovery of the visual function of vitamin A. J Nutr. 2001;131(6):1647–1650.
  • Hodge C, Taylor C. Vitamin a Deficiency. StatPearls; 2023.
  • Wirth JP, Petry N, Tanumihardjo SA, et al. Vitamin A supplementation programs and country-level evidence of vitamin A deficiency. Nutrients. 2017;9(3):1.
  • Pfeiffer CM, Sternberg MR, Schleicher RL, Haynes BM, Rybak ME, Pirkle JL. The CDC’s second national report on biochemical indicators of diet and nutrition in the U.S. Population is a valuable tool for researchers and policy makers. J Nutr. 2013;143(6):938S–47S.
  • Alkhouri RH, Hashmi H, Baker RD, Gelfond D, Baker SS. Vitamin and mineral status in patients with inflammatory bowel disease. J Pediatr Gastroenterol Nutr. 2013;56(1):89–92.
  • Venu M, Martin E, Saeian K, Gawrieh S. High prevalence of vitamin A deficiency and vitamin D deficiency in patients evaluated for liver transplantation. Liver Transpl. 2013;19(6):627–633.
  • Gilbert C. The eye signs of vitamin A deficiency. Community Eye Health. 2013;26(84):66–67.
  • Pereira A, Ertl-Wagner B, Tumber A, Vincent A, Wan MJ. Bilateral compressive optic neuropathy and outer retinopathy due to optic canal hyperostosis in a child with isolated vitamin a deficiency. Doc Ophthalmol. 2023;146(2):173–180.
  • Godfrey D, Stone RT, Lee M, Chitnis T, Santoro JD. Triad of hypovitaminosis A, hyperostosis, and optic neuropathy in males with autism spectrum disorders. Nutr Neurosci. 2022;25(8):1697–1703.
  • Tanumihardjo SA. Vitamin A: biomarkers of nutrition for development. Am J Clin Nutr. 2011;94(2):658S–65S.
  • Genead MA, Fishman GA, Lindeman M. Fundus white spots and acquired night blindness due to vitamin A deficiency. Doc Ophthalmol. 2009;119(3):229–233.
  • Ross DA. Recommendations for vitamin A supplementation. J Nutr. 2002;132(9 Suppl):2902S–2906S.
  • Martel JL, Kerndt CC, Doshi H, Franklin DS. Vitamin B1 (Thiamine). StatPearls; 2023.
  • Makarchikov AF, Lakaye B, Gulyai IE, et al. Thiamine triphosphate and thiamine triphosphatase activities: from bacteria to mammals. Cell Mol Life Sci. 2003;60(7):1477–1488.
  • Butterworth RF, Kril JJ, Harper CG. Thiamine-dependent enzyme changes in the brains of alcoholics: relationship to the Wernicke-Korsakoff syndrome. Alcohol Clin Exp Res. 1993;17(5):1084–1088.
  • Haas RH. Thiamin and the brain. Annu Rev Nutr. 1988;8:483–515.
  • Harper C. Thiamine (vitamin B1) deficiency and associated brain damage is still common throughout the world and prevention is simple and safe! Eur J Neurol. 2006;13(10):1078–1082.
  • Whitfield KC, Bourassa MW, Adamolekun B, et al. Thiamine deficiency disorders: diagnosis, prevalence, and a roadmap for global control programs. Ann N Y Acad Sci. 2018;1430(1):3–43.
  • Wiley KD, Gupta M. Vitamin B1 Thiamine Deficiency. StatPearls; 2023.
  • Whitfield KC, Karakochuk CD, Liu Y, et al. Poor thiamin and riboflavin status is common among women of childbearing age in rural and urban Cambodia. J Nutr. 2015;145(3):628–633.
  • Isen DR, Kline LB. Neuro-ophthalmic manifestations of wernicke encephalopathy. Eye Brain. 2020;12:49–60.
  • Tarnutzer AA, Straumann D. Nystagmus. Curr Opin Neurol. 2018;31(1):74–80.
  • Victor M, Adams RD, Collins GH. The Wernicke-Korsakoff syndrome. A clinical and pathological study of 245 patients, 82 with post-mortem examinations. Contemp Neurol Ser. 1971;7:1–206.
  • De la paz MA, Chung SM, McCrary JA. Bilateral internuclear ophthalmoplegia in a patient with Wernicke’s encephalopathy. J Clin Neuroophthalmol. 1992;12(2):116–120.
  • Kumar PD, Nartsupha C, West BC. Unilateral internuclear ophthalmoplegia and recovery with thiamine in Wernicke syndrome. Am J Med Sci. 2000;320(4):278–280.
  • Rakotoambinina B, Hiffler L, Gomes F. Pediatric thiamine deficiency disorders in high-income countries between 2000 and 2020: a clinical reappraisal. Ann N Y Acad Sci. 2021;1498(1):57–76.
  • Mifsud F, Messager D, Jannot AS, et al. Clinical diagnosis, outcomes and treatment of thiamine deficiency in a tertiary hospital. Clin Nutr. 2022;41(1):33–39.
  • Guo B, Gopinath B, Watson S, Burlutsky G, Mitchell P, Ooi K. Associations between intake of dietary micro- and macro-nutrients with dry eye syndrome: blue mountains eye study. Clin Nutr ESPEN. 2023;54:258–263.
  • Ren X, Chou Y, Wang Y, Jing D, Chen Y, Li X. The utility of oral vitamin B1 and mecobalamin to improve corneal nerves in dry eye disease: an in vivo confocal microscopy study. Nutrients. 2022;14(18):1.
  • Pinto JT, Zempleni J. Riboflavin. Adv Nutr. 2016;7(5):973–975.
  • Peechakara BV, Gupta M. Vitamin B2 (Riboflavin). StatPearls; 2023.
  • Ashoori M, Saedisomeolia A. Riboflavin (vitamin B(2)) and oxidative stress: a review. Br J Nutr. 2014;111(11):1985–1991.
  • Powers HJ. Riboflavin (vitamin B-2) and health. Am J Clin Nutr. 2003;77(6):1352–1360.
  • Sivaprasad M, Shalini T, Reddy PY, et al. Prevalence of vitamin deficiencies in an apparently healthy urban adult population: assessed by subclinical status and dietary intakes. Nutrition. 2019;63–64:106–113.
  • Guthrie HA, Guthrie GM. Factor analysis of nutritional status data from Ten State Nutrition Surveys. Am J Clin Nutr. 1976;29(11):1238–1241.
  • Gonzalez-Gross M, Ortega RM, Andres P, Varela G. Riboflavin status in a group of institutionalized elderly. Int J Vitam Nutr Res. 1991;61(2):120–124.
  • Sinha T, Ikelle L, Makia MS, et al. Riboflavin deficiency leads to irreversible cellular changes in the RPE and disrupts retinal function through alterations in cellular metabolic homeostasis. Redox Biol. 2022;54:102375.
  • Zhao X, Tebbe L, Naash MI, Al-Ubaidi MR. The neuroprotective role of retbindin, a metabolic regulator in the neural retina. Front Pharmacol. 2022;13:919667.
  • Froese DS, Fowler B, Baumgartner MR. Vitamin B(12), folate, and the methionine remethylation cycle-biochemistry, pathways, and regulation. J Inherit Metab Dis. 2019;42(4):673–685.
  • Naninck EFG, Stijger PC, Brouwer-Brolsma EM. The importance of maternal folate status for brain development and function of offspring. Adv Nutr. 2019;10(3):502–519.
  • Khan KM, Jialal I. Folic acid deficiency. StatPearls; 2023.
  • Green R, Allen LH, Bjorke-Monsen AL, et al. Vitamin B(12) deficiency. Nat Rev Dis Primers. 2017;3:17040.
  • van der Wal HH, Comin-Colet J, Klip IT, et al. Vitamin B12 and folate deficiency in chronic heart failure. Heart. 2015;101(4):302–310.
  • Bailey RL, West KP Jr, Black RE. The epidemiology of global micronutrient deficiencies. Ann Nutr Metab. 2015;66(Suppl 2):22–33.
  • Orssaud C, Roche O, Dufier JL. Nutritional optic neuropathies. J Neurol Sci. 2007;262(1–2):158–164.
  • Sawicka-Pierko A, Obuchowska I, Mariak Z. Nutritional optic neuropathy. Klin Oczna. 2014;116(2):104–110.
  • Golnik KC, Schaible ER. Folate-responsive optic neuropathy. J Neuroophthalmol. 1994;14(3):163–169.
  • de Silva P, Jayamanne G, Bolton R. Folic acid deficiency optic neuropathy: a case report. J Med Case Rep. 2008;2:299.
  • Chen Z, Yu L, Li W, et al. Association of vitamins with hearing loss, vision disorder and sleep problem in the US general population. Environ Sci Pollut Res Int. 2023;2023:1.
  • Rochtchina E, Wang JJ, Flood VM, Mitchell P. Elevated serum homocysteine, low serum vitamin B12, folate, and age-related macular degeneration: the blue mountains eye study. Am J Ophthalmol. 2007;143(2):344–346.
  • Huang P, Wang F, Sah BK, et al. Homocysteine and the risk of age-related macular degeneration: a systematic review and meta-analysis. Sci Rep. 2015;5:10585.
  • Orjuela MA, Cabrera-Munoz L, Paul L, et al. Risk of retinoblastoma is associated with a maternal polymorphism in dihydrofolatereductase (DHFR) and prenatal folic acid intake. Cancer. 2012;118(23):5912–5919.
  • Roda M, Di Geronimo N, Pellegrini M, Schiavi C. Nutritional optic neuropathies: state of the art and emerging evidences. Nutrients. 2020;12(9):1.
  • Green R, Datta Mitra A. Megaloblastic anemias: nutritional and other causes. Med Clin North Am. 2017;101(2):297–317.
  • Krautler B. Vitamin B12: chemistry and biochemistry. Biochem Soc Trans. 2005;33(Pt 4):806–810.
  • Ankar A, Kumar A. Vitamin B12 Deficiency. StatPearls; 2023.
  • Pawlak R, Lester SE, Babatunde T. The prevalence of cobalamin deficiency among vegetarians assessed by serum vitamin B12: a review of literature. Eur J Clin Nutr. 2016;70(7):866.
  • Pflipsen MC, Oh RC, Saguil A, Seehusen DA, Seaquist D, Topolski R. The prevalence of vitamin B(12) deficiency in patients with type 2 diabetes: a cross-sectional study. J Am Board Fam Med. 2009;22(5):528–534.
  • Damiao CP, Rodrigues AO, Pinheiro MF, et al. Prevalence of vitamin B12 deficiency in type 2 diabetic patients using metformin: a cross-sectional study. Sao Paulo Med J. 2016;134(6):473–479.
  • Stambolian D, Behrens M. Optic neuropathy associated with vitamin B12 deficiency. Am J Ophthalmol. 1977;83(4):465–468.
  • Nightingale LM, Paviour DC. Nutritional optic and peripheral neuropathy: a case report. Cases J. 2009;2:7762.
  • Ata F, Bint IBA, Javed S, et al. Optic neuropathy as a presenting feature of vitamin B-12 deficiency: a systematic review of literature and a case report. Ann Med Surg. 2020;60:316–322.
  • Ren X, Chou Y, Jiang X, et al. Effects of oral vitamin B1 and mecobalamin on dry eye disease. J Ophthalmol. 2020;2020:9539674.
  • Ozen S, Ozer MA, Akdemir MO. Vitamin B12 deficiency evaluation and treatment in severe dry eye disease with neuropathic ocular pain. Graefes Arch Clin Exp Ophthalmol. 2017;255(6):1173–1177.
  • Shetty R, Deshpande K, Ghosh A, Sethu S. Management of ocular neuropathic pain with vitamin B12 supplements: a case report. Cornea. 2015;34(10):1324–1325.
  • Padh H. Vitamin C: newer insights into its biochemical functions. Nutr Rev. 1991;49(3):65–70.
  • Figueroa-Mendez R, Rivas-Arancibia S. Vitamin C in health and disease: its role in the metabolism of cells and redox state in the brain. Front Physiol. 2015;6:397.
  • Jacob RA, Sotoudeh G. Vitamin C function and status in chronic disease. Nutr Clin Care. 2002;5(2):66–74.
  • Padayatty SJ, Katz A, Wang Y, et al. Vitamin C as an antioxidant: evaluation of its role in disease prevention. J Am Coll Nutr. 2003;22(1):18–35.
  • Cahill L, Corey PN, El-Sohemy A. Vitamin C deficiency in a population of young Canadian adults. Am J Epidemiol. 2009;170(4):464–471.
  • Hirschmann JV, Raugi GJ. Adult scurvy. J Am Acad Dermatol. 1999;41(6):895–906; quiz 907–10.
  • Grosso G, Bei R, Mistretta A, et al. Effects of vitamin C on health: a review of evidence. Front Biosci. 2013;18(3):1017–1029.
  • Greco AM, Fioretti F, Rimo A. Relationship between hemorrhagic ocular diseases and vitamin C deficiency: clinical and experimental data. Acta Vitaminol Enzymol. 1980;2(1–2):21–25.
  • Eye Disease Study Research G A-R. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Arch Ophthalmol. 2001;119(10):1417–1436.
  • Seddon JM, Ajani UA, Sperduto RD, et al. Dietary carotenoids, vitamins A, C, and E, and advanced age-related macular degeneration. Eye disease case-control study group. JAMA. 1994;272(18):1413–1420.
  • Chylack LT Jr, Brown NP, Bron A, et al. The Roche European American Cataract Trial (REACT): a randomized clinical trial to investigate the efficacy of an oral antioxidant micronutrient mixture to slow progression of age-related cataract. Ophthalmic Epidemiol. 2002;9(1):49–80.
  • Izzotti A, Bagnis A, Sacca SC. The role of oxidative stress in glaucoma. Mutat Res. 2006;612(2):105–114.
  • Yuki K, Murat D, Kimura I, Ohtake Y, Tsubota K. Reduced-serum vitamin C and increased uric acid levels in normal-tension glaucoma. Graefes Arch Clin Exp Ophthalmol. 2010;248(2):243–248.
  • Wang SY, Singh K, Lin SC. Glaucoma and vitamins A, C, and E supplement intake and serum levels in a population-based sample of the United States. Eye. 2013;27(4):487–494.
  • Moise MM, Benjamin LM, Doris TM, Dalida KN, Augustin NO. Role of Mediterranean diet, tropical vegetables rich in antioxidants, and sunlight exposure in blindness, cataract and glaucoma among African type 2 diabetics. Int J Ophthalmol. 2012;5(2):231–237.
  • Group AR, Chew EY, Clemons T, et al. The Age-Related Eye Disease Study 2 (AREDS2): study design and baseline characteristics (AREDS2 report number 1). Ophthalmology. 2012;119(11):2282–2289.
  • Monsen ER. Dietary reference intakes for the antioxidant nutrients: vitamin C, vitamin E, selenium, and carotenoids. J Am Diet Assoc. 2000;100(6):637–640.
  • DeLuca HF, Zierold C. Mechanisms and functions of vitamin D. Nutr Rev. 1998;56(2 Pt 2):S4–10.
  • Prietl B, Treiber G, Pieber TR, Amrein K. Vitamin D and immune function. Nutrients. 2013;5(7):2502–2521.
  • Rullo J, Pennimpede T, Mehraban Far P, et al. Intraocular calcidiol: uncovering a role for vitamin D in the eye. J Steroid Biochem Mol Biol. 2020;197:105536.
  • Sarafin K, Durazo-Arvizu R, Tian L, et al. Standardizing 25-hydroxyvitamin D values from the Canadian Health Measures Survey. Am J Clin Nutr. 2015;102(5):1044–1050.
  • Amrein K, Scherkl M, Hoffmann M, et al. Vitamin D deficiency 2.0: an update on the current status worldwide. Eur J Clin Nutr. 2020;74(11):1498–1513.
  • Bouillon R, Carmeliet G, Verlinden L, et al. Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev. 2008;29(6):726–776.
  • Thacher TD, Pludowski P, Shaw NJ, Mughal MZ, Munns CF, Hogler W. Nutritional rickets in immigrant and refugee children. Public Health Rev. 2016;37:3.
  • Plum LA, DeLuca HF. Vitamin D, disease and therapeutic opportunities. Nat Rev Drug Discov. 2010;9(12):941–955.
  • The epidemiology of dry eye disease: report of the epidemiology subcommittee of the international dry eye WorkShop (2007). Ocul Surf. 2007;5(2):93–107.
  • Yoon SY, Bae SH, Shin YJ, et al. Low serum 25-hydroxyvitamin D levels are associated with dry eye syndrome. PLoS One. 2016;11(1):e0147847.
  • Liu J, Dong Y, Wang Y. Vitamin D deficiency is associated with dry eye syndrome: a systematic review and meta-analysis. Acta Ophthalmol. 2020;98(8):749–754.
  • Suzuki A, Kotake M, Ono Y, et al. Hypovitaminosis D in type 2 diabetes mellitus: association with microvascular complications and type of treatment. Endocr J. 2006;53(4):503–510.
  • Ahmed LHM, Butler AE, Dargham SR, et al. Relationship between total vitamin D metabolites and complications in patients with type 2 diabetes. Biomed Rep. 2021;14(1):18.
  • Cade C, Norman AW. Vitamin D3 improves impaired glucose tolerance and insulin secretion in the vitamin D-deficient rat in vivo. Endocrinology. 1986;119(1):84–90.
  • Goncalves A, Milea D, Gohier P, et al. Serum vitamin D status is associated with the presence but not the severity of primary open angle glaucoma. Maturitas. 2015;81(4):470–474.
  • Ayyagari R, Chen Y-DI, Zangwill LM, et al. Association of severity of primary open-angle glaucoma with serum vitamin D levels in patients of African descent. Mol Vis. 2019;25:438–445.
  • Kutuzova GD, Gabelt BT, Kiland JA, Hennes-Beann EA, Kaufman PL, DeLuca HF. 1α,25-Dihydroxyvitamin D3 and its analog, 2-methylene-19-nor-(20S)-1α,25-dihydroxyvitamin D3 (2MD), suppress intraocular pressure in non-human primates. Arch Biochem Biophys. 2012;518(1):53–60.
  • Krefting EA, Jorde R, Christoffersen T, Grimnes G. Vitamin D and intraocular pressure--results from a case-control and an intervention study. Acta Ophthalmol. 2014;92(4):345–349.
  • Delcourt C, Carriere I, Ponton-Sanchez A, Lacroux A, Covacho MJ, Papoz L. Light exposure and the risk of cortical, nuclear, and posterior subcapsular cataracts: the Pathologies Oculaires Liees a l’Age (POLA) study. Arch Ophthalmol. 2000;118(3):385–392.
  • Rao P, Millen AE, Meyers KJ, et al. The relationship between serum 25-hydroxyvitamin D levels and nuclear cataract in the Carotenoid Age-Related Eye Study (CAREDS), an ancillary study of the women’s health initiative. Invest Ophthalmol Vis Sci. 2015;56(8):4221–4230.
  • Park S, Choi NK. Serum 25-hydroxyvitamin D and Age-Related Cataract. Ophthalmic Epidemiol. 2017;24(5):281–286.
  • Abdellah MM, Mohamed Mostafa E, Salama EH, Roshdy Mohamed E. Association of serum 25-hydroxyl vitamin D deficiency and age-related cataract: a case-control study. J Ophthalmol. 2019;2019:9312929.
  • Millen AE, Voland R, Sondel SA, et al. Vitamin D status and early age-related macular degeneration in postmenopausal women. Arch Ophthalmol. 2011;129(4):481–489.
  • Kim KL, Park SP. Association between serum vitamin D deficiency and age-related macular degeneration in Koreans: clinical case-control pilot study. Medicine. 2018;97(33):e11908.
  • Merle BMJ, Silver RE, Rosner B, Seddon JM. Associations between vitamin D intake and progression to incident advanced age-related macular degeneration. Invest Ophthalmol Vis Sci. 2017;58(11):4569–4578.
  • Singh A, Falk MK, Subhi Y, Sorensen TL. The association between plasma 25-hydroxyvitamin D and subgroups in age-related macular degeneration: a cross-sectional study. PLoS One. 2013;8(7):e70948.
  • Munger KL, Zhang SM, O’Reilly E, et al. Vitamin D intake and incidence of multiple sclerosis. Neurology. 2004;62(1):60–65.
  • Munger KL, Levin LI, Hollis BW, Howard NS, Ascherio A. Serum 25-hydroxyvitamin D levels and risk of multiple sclerosis. JAMA. 2006;296(23):2832–2838.
  • Salzer J, Hallmans G, Nystrom M, Stenlund H, Wadell G, Sundstrom P. Vitamin D as a protective factor in multiple sclerosis. Neurology. 2012;79(21):2140–2145.
  • Rhead B, Baarnhielm M, Gianfrancesco M, et al. Mendelian randomization shows a causal effect of low vitamin D on multiple sclerosis risk. Neurol Genet. 2016;2(5):e97.
  • Munger KL, Aivo J, Hongell K, Soilu-Hanninen M, Surcel HM, Ascherio A. Vitamin D status during pregnancy and risk of multiple sclerosis in offspring of women in the Finnish maternity cohort. JAMA Neurol. 2016;73(5):515–519.
  • Ascherio A, Munger KL, White R, et al. Vitamin D as an early predictor of multiple sclerosis activity and progression. JAMA Neurol. 2014;71(3):306–314.
  • Laursen JH, Sondergaard HB, Sorensen PS, Sellebjerg F, Oturai AB. Vitamin D supplementation reduces relapse rate in relapsing-remitting multiple sclerosis patients treated with natalizumab. Mult Scler Relat Disord. 2016;10:169–173.
  • Simpson-Yap S, Jelinek P, Weiland T, Nag N, Neate S, Jelinek G. Self-reported use of vitamin D supplements is associated with higher physical quality of life scores in multiple sclerosis. Mult Scler Relat Disord. 2021;49:102760.
  • Stein MS, Liu Y, Gray OM, et al. A randomized trial of high-dose vitamin D2 in relapsing-remitting multiple sclerosis. Neurology. 2011;77(17):1611–1618.
  • Kampman MT, Steffensen LH, Mellgren SI, Jorgensen L. Effect of vitamin D3 supplementation on relapses, disease progression, and measures of function in persons with multiple sclerosis: exploratory outcomes from a double-blind randomised controlled trial. Mult Scler. 2012;18(8):1144–1151.
  • Pihl-Jensen G, Frederiksen JL. 25-Hydroxyvitamin D levels in acute monosymptomatic optic neuritis: relation to clinical severity, paraclinical findings and risk of multiple sclerosis. J Neurol. 2015;262(7):1646–1654.
  • Burton JM, Eliasziw M, Trufyn J, Tung C, Carter G, Costello F. A prospective cohort study of vitamin D in optic neuritis recovery. Mult Scler. 2017;23(1):82–93.
  • Planck T, Shahida B, Malm J, Manjer J. Vitamin D in graves disease: levels, correlation with laboratory and clinical parameters, and genetics. Eur Thyroid J. 2018;7(1):27–33.
  • Sadaka A, Nguyen K, Malik A, Brito R, Berry S, Lee AG. Vitamin D and selenium in a thyroid eye disease population in Texas. Neuroophthalmology. 2019;43(5):291–294.
  • Heisel CJ, Riddering AL, Andrews CA, Kahana A. Serum vitamin D deficiency is an independent risk factor for thyroid eye disease. Ophthalmic Plast Reconstr Surg. 2020;36(1):17–20.
  • Saulenas AM, Cohen SM, Key LL, Winter C, Albert DM. Vitamin D and retinoblastoma. The presence of receptors and inhibition of growth in vitro. Arch Ophthalmol. 1988;106(4):533–535.
  • Kulkarni AD, van Ginkel PR, Darjatmoko SR, Lindstrom MJ, Albert DM. Use of combination therapy with cisplatin and calcitriol in the treatment of Y-79 human retinoblastoma xenograft model. Br J Ophthalmol. 2009;93(8):1105–1108.
  • Orjuela-Grimm M, Carreno SB, Liu X, et al. Sunlight exposure in infancy decreases risk of sporadic retinoblastoma, extent of intraocular disease. Cancer Rep. 2021;4(6):e1409.
  • Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2011;96(7):1911–1930.
  • Calvo MS, Whiting SJ, Barton CN. Vitamin D fortification in the United States and Canada: current status and data needs. Am J Clin Nutr. 2004;80(6 Suppl):1710S–6S.
  • Brigelius-Flohe R, Traber MG. Vitamin E: function and metabolism. FASEB J. 1999;13(10):1145–1155.
  • Evans HM, Bishop KS. On the existence of a hitherto unrecognized dietary factor essential for reproduction. Science. 1922;56(1458):650–651.
  • Herrera E, Barbas C. Vitamin E: action, metabolism and perspectives. J Physiol Biochem. 2001;57(1):43–56.
  • Traber MG. Does vitamin E decrease heart attack risk? Summary and implications with respect to dietary recommendations. J Nutr. 2001;131(2):395S–7S.
  • Maras JE, Bermudez OI, Qiao N, Bakun PJ, Boody-Alter EL, Tucker KL. Intake of alpha-tocopherol is limited among US adults. J Am Diet Assoc. 2004;104(4):567–575.
  • Dror DK, Allen LH. Vitamin E deficiency in developing countries. Food Nutr Bull. 2011;32(2):124–143.
  • Ouahchi K, Arita M, Kayden H, et al. Ataxia with isolated vitamin E deficiency is caused by mutations in the alpha-tocopherol transfer protein. Nat Genet. 1995;9(2):141–145.
  • Wetterau JR, Aggerbeck LP, Bouma ME, et al. Absence of microsomal triglyceride transfer protein in individuals with abetalipoproteinemia. Science. 1992;258(5084):999–1001.
  • Cogan DG, Rodrigues M, Chu FC, Schaefer EJ. Ocular abnormalities in abetalipoproteinemia. A clinicopathologic correlation. Ophthalmology. 1984;91(8):991–998.
  • Chowers I, Banin E, Merin S, Cooper M, Granot E. Long-term assessment of combined vitamin A and E treatment for the prevention of retinal degeneration in abetalipoproteinaemia and hypobetalipoproteinaemia patients. Eye. 2001;15(Pt 4):525–530.
  • Runge P, Muller DP, McAllister J, Calver D, Lloyd JK, Taylor D. Oral vitamin E supplements can prevent the retinopathy of abetalipoproteinaemia. Br J Ophthalmol. 1986;70(3):166–173.
  • Saugstad OD. Oxygen and retinopathy of prematurity. J Perinatol. 2006;26(Suppl 1):S46–50.
  • Muller DP. Vitamin E therapy in retinopathy of prematurity. Eye. 1992;6(Pt 2):221–225.
  • Johnson L, Quinn GE, Abbasi S, et al. Effect of sustained pharmacologic vitamin E levels on incidence and severity of retinopathy of prematurity: a controlled clinical trial. J Pediatr. 1989;114(5):827–838.
  • Romero-Maldonado S, Montoya-Estrada A, Reyes-Munoz E, et al. Efficacy of water-based vitamin E solution versus placebo in the prevention of retinopathy of prematurity in very low birth weight infants: a randomized clinical trial. Medicine. 2021;100(31):e26765.
  • Delcourt C, Cristol JP, Tessier F, Leger CL, Descomps B, Papoz L. Age-related macular degeneration and antioxidant status in the POLA study. POLA Study Group. Pathologies Oculaires Liees a l’Age. Arch Ophthalmol. 1999;117(10):1384–1390.
  • Belda JI, Roma J, Vilela C, et al. Serum vitamin E levels negatively correlate with severity of age-related macular degeneration. Mech Ageing Dev. 1999;107(2):159–164.
  • Sokol RJ, Heubi JE, Iannaccone ST, Bove KE, Balistreri WF. Vitamin E deficiency with normal serum vitamin E concentrations in children with chronic cholestasis. N Engl J Med. 1984;310(19):1209–1212.
  • Traber MG, Jialal I. Measurement of lipid-soluble vitamins--further adjustment needed? Lancet. 2000;355(9220):2013–2014.
  • Zamel R, Khan R, Pollex RL, Hegele RA. Abetalipoproteinemia: two case reports and literature review. Orphanet J Rare Dis. 2008;3:19.
  • Choi EY, Neustein RF, Krebs NF, Walton DS. Ocular manifestations of vitamin disorders. The Eye in Pediatric Systemic Disease. Springer; 2017:773–785.
  • Marchili MR, Santoro E, Marchesi A, Bianchi S, Rotondi Aufiero L, Villani A. Vitamin K deficiency: a case report and review of current guidelines. Ital J Pediatr. 2018;44(1):36.
  • Wille H. Investigations in the influence of K avitaminosis in the occurrence of retinal hemorrhages in the newborn: a preliminary report. Acta Ophthalmol. 1944;22(3):261–269.
  • Wetzel RC, Slater AJ, Dover GJ. Fatal intramuscular bleeding misdiagnosed as suspected nonaccidental injury. Pediatrics. 1995;95(5):771–773.
  • Matsuzaka T, Yoshinaga M, Tsuji Y, Yasunaga A, Mori K. Incidence and causes of intracranial hemorrhage in infancy: a prospective surveillance study after vitamin K prophylaxis. Brain Dev. 1989;11(6):384–388.
  • Lane PA, Hathaway WE, Githens JH, Krugman RD, Rosenberg DA. Fatal intracranial hemorrhage in a normal infant secondary to vitamin K deficiency. Pediatrics. 1983;72(4):562–564.
  • Eden RE, Coviello JM. Vitamin K Deficiency. StatPearls; 2023.
  • American Academy of Pediatrics Committee on F, Newborn. Controversies concerning vitamin K and the newborn. American Academy of Pediatrics Committee on fetus and newborn. Pediatrics. 2003;112(1 Pt 1):191–192.
  • Per H, Kumandas S, Ozdemir MA, Gumus H, Karakukcu M. Intracranial hemorrhage due to late hemorrhagic disease in two siblings. J Emerg Med. 2006;31(1):49–52.